Data / Form D filings / Novastream Therapeutics Inc.
Novastream Therapeutics Inc.: Form D filing
Novastream Therapeutics Inc., a biotechnology company in Denver, CO, filed a Form D with the SEC in 2023. The latest, on October 17, 2023, reports $50,000 sold of a $250,000 offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5595 WASHINGTON STREET, Denver, CO, 80216
- Phone
- (720) 924-9237
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1997658
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 17, 2023 | New notice | $250,000 | $50,000 | $200,000 | 4 | Oct 3, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Manuel Ornelas | Executive Officer, Director | |
| Mark Webb | Director | |
| Jason Novak | Director | |
| Thomas Kluz | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Oct 16, 2023 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Novastream Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.